Emvision Medical Devices Ltd has released a press release.
Appendix 4C - quarterly
Filed with ASX ·
6ix hasn’t read this filing yet.
EMvision Medical Devices Ltd. on 6ix
Earlier from EMvision Medical Devices
- S&P DJI Announces March 2021 Quarterly Rebalance
- Successful MRFF Bid
- Half Year Report & CEO Update
- EMVision Reports Very Encouraging Pilot Clinical Trial Data
- EMVision Completes 30 Patient Enrolment
Later from EMvision Medical Devices
- Clinical Research Partnership Signed with Metro South Health
- EMVision 1st Generation Device Progressing Well
- 1st Gen Device Successfully Manufactured & Ready for Testing
- Appendix 4E & Annual Report 30 June 2021
- ASA & EMVision Sign $8m Project Agreement
Follow EMvision Medical Devices into a list and get an email when it puts out news.
Follow EMvision Medical Devices